Poxel was able to score positive results for its type 2 diabetes drug in a Phase IIb study in Japan, preparing the company to go for a Phase III program. Poxel, one of
Tag "France"
On Feb. 23, 2017, Novasep announced the opening of its new €11-million (approximately $11.64 million) bioconjugation unit in the company’s Le Mans site in France. The 2000m facility includes two
Biopharmaceutical, analytical and bioanalytical contract solutions provider, SGS has announced that it is expanding its elemental analysis and testing capabilities at its Villeneuve-la-Garenne, France laboratory. The site has invested in
Advertisements
